Quick Answer
GRI Bio, Inc. reported Net Income of -$11.96 million for fiscal year 2025.
GRI Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$11.96M | -45.7% |
| 2024 | -$8.21M | +37.0% |
| 2023 | -$13.04M | -305.3% |
| 2022 | -$3.22M | +65.4% |
| 2021 | -$9.30M | -92.9% |
| 2020 | -$4.82M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.36M | -58.2% | -16.1% |
| June 30, 2025 | -$2.89M | -28.5% | +5.1% |
| March 31, 2025 | -$3.05M | -61.4% | -43.5% |
| September 30, 2024 | -$2.12M | +0.7% | +5.6% |
| June 30, 2024 | -$2.25M | +66.6% | -19.2% |
| March 31, 2024 | -$1.89M | +12.2% | +11.7% |
| September 30, 2023 | -$2.14M | -508.8% | +68.3% |
| June 30, 2023 | -$6.75M | -2186.8% | -213.8% |
- GRI Bio, Inc. showed a decrease of -45.7% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, GRI Bio, Inc.’s net income has declined by 147.9% (from -$4.82 million to -$11.96 million).
- The most recent figure is from GRI Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: